Glucagon sensitivity and clearance in type 1 diabetes: insights from in vivo and in silico experiments.
about
Cross-Validation of a Glucose-Insulin-Glucagon Pharmacodynamics Model for Simulation Using Data From Patients With Type 1 Diabetes.Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.The UVA/Padova Type 1 Diabetes Simulator Goes From Single Meal to Single Day.Efficacy of single-hormone and dual-hormone artificial pancreas during continuous and interval exercise in adult patients with type 1 diabetes: randomised controlled crossover trial.Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
P2860
Glucagon sensitivity and clearance in type 1 diabetes: insights from in vivo and in silico experiments.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Glucagon sensitivity and clear ...... ivo and in silico experiments.
@ast
Glucagon sensitivity and clear ...... ivo and in silico experiments.
@en
type
label
Glucagon sensitivity and clear ...... ivo and in silico experiments.
@ast
Glucagon sensitivity and clear ...... ivo and in silico experiments.
@en
prefLabel
Glucagon sensitivity and clear ...... ivo and in silico experiments.
@ast
Glucagon sensitivity and clear ...... ivo and in silico experiments.
@en
P2093
P2860
P1476
Glucagon sensitivity and clear ...... ivo and in silico experiments.
@en
P2093
Ananda Basu
Ashwini Mallad
Ling Hinshaw
Rickey E Carter
Yogish C Kudva
P2860
P304
P356
10.1152/AJPENDO.00236.2015
P577
2015-07-07T00:00:00Z